No Data
No Data
LifeMD to Report Fourth Quarter 2024 Financial Results on March 10
Mizuho Securities Maintains LifeMD(LFMD.US) With Hold Rating, Announces Target Price $7
LifeMD Expands Services to Include Teletherapy and Psychiatry, Led by Industry Veteran Julian Cohen
LifeMD Expands Into the Behavioral Health Market. The Move Broadens LifeMD's Service Offerings To Include Teletherapy, Psychiatry And Medication Management For Common Mental Health Conditions.
LifeMD Announces Entry Into the Behavioral Health Market
Loss-Making LifeMD, Inc. (NASDAQ:LFMD) Expected To Breakeven In The Medium-Term